Cerebras's yield problem is not solved, because the fault tolerance it claims comes at a price. Wafer-scale chips need testing, retesting of repairable defects and repair, and long bypass routes around defects can fail higher-speed specifications. @damnang2 lays out the details in a yield model for the WSE-3 built from Cerebras's public disclosures, though by his own account the figures rest on his assumptions, not Cerebras's actual yield. x.com 

Cerebras is heavily overvalued at 62.7x EV/sales, even though it can re-rate as HBM stays rationed across the GPU world. Its wafer carries 44GB of SRAM, skipping the HBM queue, the latest quarter grew 74% with a $25.4B backlog, and its customer list should broaden beyond two UAE-linked buyers. Adding makes sense only near $186. If G42 and MBZUAI slow their orders, that multiple has nothing under it. x.com 

Cerebras looks attractive because the short report's two-year wafer-life thesis rests on unvalidated reliability assumptions, not representative failure data. Energy per useful token, lower warranty utilization and ordinary repair accounting also undercut its financial conclusions. OpenAI has integrated Cerebras into production; AMD and AWS have announced integrations, while Oracle plans 2027 availability for ultra-fast inference, adding commercial validation despite the report. x.com  x.com 

Cerebras at over 100x sales with execution hurdles is not a low-risk buy, so it is better to sit out for now. It is a pure AI hardware bet: if wafer-scale chips take meaningful share from NVIDIA and revenue grows 2-4x or more in two years, the roughly $237 price could look reasonable long term. It suits only aggressive growth investors who can stomach 30-50% swings. x.com 

Cerebras is priced like Nvidia but works more like a niche decode accelerator. At about 100x sales with heavy revenue concentration after its $52 billion IPO, the stock assumes a general-purpose AI platform. Per a deep dive on Damnang's Substack, its 44GB of on-chip SRAM gives unmatched low-latency decode but cannot hold today's large frontier mixture-of-experts models, pushing data onto slower external memory, and its fixed FP16 compute lags the industry's move to FP8 and FP4. x.com 

Better power delivery appears to be helping Cerebras work through wafer-scale power and thermal limits more than expected. CS-4 gets higher clocks and improved I/O from WSE-3T, despite the same core count and SRAM capacity as WSE-3. Oracle, OpenAI and AWS choosing to work with Cerebras carries weight. But higher clocks do not answer Culper Research's allegation that its wafers fail after about two years; how representative those failures are of current systems remains unclear. x.com 

Cerebras is unattractive to buy at a valuation above $60 billion while its product remains unproven at scale. x.com 

Cerebras's share price already assumes years of flawless execution, so investors can be right about the company long term and still lose money. Two customers make up 86% of revenue, it posted a $146 million operating loss in 2025, its GAAP profit came from accounting gains, and it trades at 111x revenue. The wafer-scale technology, 15x faster AI inference and $20B+ OpenAI compute deal make the bull case real, but the price leaves no margin for early-stage setbacks. x.com 

Vicor's efficient delivery of key power modules is part of the case for Cerebras meeting and exceeding its 2028-29 numbers. As models improve, more security breaches and deployments should make Cerebras look increasingly like a cybersecurity play. Its revenue ramp looks constrained by capacity, not yet by demand. Bullish on Cerebras but cautious on the broader market, with no short-term earnings prediction. x.com  x.com  x.com  x.com 

Cerebras' bull case requires implausible growth: its hardware revenue rose only $146M from 2024 to 2025, so expecting $1.6B more in 2026 is laughable. @balmy_investor bets on $2B of 2026 hardware revenue and nearly $3B with cloud services, which would be 20x 2025 revenue at a $60B market cap. x.com